MCV4

MCV4

meningococcal (groups A, C, Y, and W-135) conjugate vaccine.
References in periodicals archive ?
Despite the absence of serogroup B component in MCV4, declines in serogroup B disease were reported in addition to vaccine serogroups C and Y.
Students entering the seventh and twelfth grades in West Virginia for the 2015-2016 school year must show proof of age-appropriate Tdap (tetanus, diphtheria and pertussis) and MCV4 (meningitis) vaccinations.
The incidence of disease caused by meningococcal serotype B, which MCV4 does not protect against, has also declined from 0.
The Phase II trial met its co-primary immunogenicity objectives pertaining to co-administration of Trumenba with MCV4 and Tdap vaccines.
With the expanded indication for this MCV4 vaccine, we now have the opportunity to help protect our infants against four strains of meningococcal disease earlier, when they are most vulnerable.
TravelSafe Clinic, India now offers the latest MCV4 vaccine (Menactra) at all its centers in Chandigarh, Delhi & Mumbai.
The increase in vaccine coverage rates for human papillomavirus (HPV) vaccine, however, is only about half the rate of the increases seen for Tdap and MCV4.
In 2010, 80 percent of teens receive the Tdap vaccine and 63 percent got the MCV4 shot.
MCV4 footnotes have been updated to reflect recent recommendations published in MMWR.
As the proportion of children receiving MCV4 continues to increase, we expect additional reductions in the incidence of meningococcal disease," the investigators said.
MCV4, 11 ila 55 yas arasindaki hastaliga yakalanma olasiligi tasiyan bireylere onerilmektedir.
Revaccination with MCV4 after 5 years is recommended for individuals who continue to be at risk for infection, such as adults with anatomic or functional asplenia.